- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02346825
The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project) (The Baby CHAMP)
Multisite RCT of 3 Neurorehabilitation Therapies for Infants With Asymmetrical Cerebral Palsy
Study Overview
Status
Conditions
Detailed Description
In 2013, a systematic review of interventions for children with cerebral palsy (Novak et al, 2013) concluded that constraint-induced movement therapy (CIMT) produces the largest magnitude effects of any non-surgical treatment. Similarly, the first major handbook summarizing the results from more than 50 studies on CIMT conducted worldwide (Ramey, Coker-Bolt, & DeLuca, 2013) provides additional clinical and scientific support for the conclusion that CIMT can produce significant benefits. There are a number of important unresolved issues. One concerns the need for empirical evidence that CIMT is efficacious for infants and toddlers, since there has been no randomized controlled trial (RCT) focused on this age range. Another issue under debate is whether there are different effects related to the type of constraint used during the therapy. The constraint is placed on the child's "stronger" or non-hemiparetic upper extremity while the therapy focuses on improving the child's skills in using the impaired or hemiparetic upper extremity. Two widely used forms of constraint are: 1) a full-arm cast that the child wears continuously throughout a multi-week period when the child receives daily therapy and 2) a part-arm splint that the child wears only during the time of day when he or she receives therapy. Finally, another important topic that has not been studied is whether CIMT is a stressful form of therapy, because it is high-intensity (i.e., much higher dosage than the usual and customary sessions in other forms of occupational and physical therapy), involves constraining the child's non-involved or less involved upper extremity, and takes place in the child's home and often asks parents to help with practice sessions during non-therapy hours. If CIMT does produce elevated stress for the child, the parents, or both, is this stress short-term (i.e., just at the start of therapy) or does this continues over the entire period of therapy? Further, does the type of constraint used produce different levels of stress, either at first or throughout the course of therapy?
The proposed study is a randomized controlled trial (RCT) of CIMT for 72 children with hemiparetic spastic cerebral palsy (CP) between the ages of 6 and 24 months. The study will take place in two sites (Roanoke, VA and Columbus, OH), each site enrolling 36 children over a 3 year period. The study will address two specific aims:
Aim 1: to test the efficacy of 3 different constraint conditions used as part of administering a standardized form of therapy known as ACQUIRE (DeLuca, Echols, & Ramey, 2007). The 3 constraint conditions are: i) continuous constraint, ii) part-time constraint, and iii) no constraint. In all 3 groups, children will receive 3 hours of therapy per day for 5 days per week for 4 consecutive days. Therapy is delivered by licensed occupation or physical therapists who have been trained to deliver ACQUIRE therapy to high fidelity. In addition, parents are trained to provide one hour of practice in their homes, using techniques compatible with those used by the ACQUIRE therapist. Efficacy will be measured primarily by changes in the children's assessed skill levels in using their upper extremities, both the hemiparetic (affected) and the non-hemiparetic (less involved) upper extremities, used alone and together (i.e., in completing bimanual tasks). In addition, changes in brain functioning related to receiving the 3 different constraint conditions will be measured using functional Near-Infrared Spectroscopy (fNIRS), a non-invasive and safe procedure that permits children to be active while recording takes place.
Aim 2: to monitor stress levels and safety risks related to use of constraint in the 3 conditions identified above (Aim 1). The study addresses stress levels in both the children and their parents, because CIMT is a high-intensity and unusual (i.e., constraining the child's "stronger arm") form of therapy taking place in the children's homes. Prior published clinical case reports indicate infants and toddlers adjust well to this form of therapy, and parents have favorable responses, no study previously has directly measured stress effects, related to self-report of parents or biological indicators, such as revealed by collecting saliva and hair samples to analyze for cortisol levels and changes over time.
The study results are expected to be important to inform the field of infant rehabilitation and provide much-needed evidence about whether infants and toddlers show significant (clinically meaningful) benefits from one or more of the 3 forms of therapy being tested. The findings will include evidence about both behavioral and brain changes. Further, the evidence will answer questions about whether the immediate therapy benefits, if detected, continue to be measurable at 6 and 12 months after therapy has ended. In addition, the study will yield first-ever evidence about whether CIMT is stressful for children and their parents. It may be there are some children or parents who are at higher risk for showing stress effects. If so, the data generated by this study will be important for future clinical practice and research to reduce these levels. If elevated stress does not occur, or if markedly lowering of stress is detected, then these findings will help to resolve the uncertainty that currently prevents some families or clinicians from considering this form of therapy, despite the fact that other scientific studies have shown it produces large and lasting benefits for children age 2 and older.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States
- The Ohio State University
-
-
Virginia
-
Charlottesville, Virginia, United States
- University of Virginia
-
Roanoke, Virginia, United States, 24016
- Fralin Biomedical Research Institute at Virginia Tech
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- child is 6 - 24 months old
- diagnosis of unilateral/asymmetrical Cerebral Palsy
- has functional upper extremity impairment levels of II, III, or IV (Manual Abilities Classification System, Eliasson et al 2006)
- parent(s) willing to be partners in study and participate in follow-up assessments for 12 mos.
Exclusion Criteria:
- medical or sensory condition that prevents full therapy participation (e.g., frequent uncontrolled seizures, blindness)
- received CIMT or had botulinum toxin therapy in past 6 mos.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intensive Plus Cast
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks while wearing a full-arm cast on their stronger arm and hand.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
|
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks while wearing a full-arm cast on their stronger arm and hand.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
Other Names:
|
Experimental: Intensive Plus Splint
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks while wearing a part-time splint on their stronger arm and hand.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
|
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks while wearing part-time splint on their stronger arm and hand.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
Other Names:
|
Experimental: Intensive no Constraint
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks but will not wear a constraint.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
|
Children in this group will have 3 hours of daily therapy each weekday for 4 weeks will not wear a constraint.
Parents will be required to do 45 minutes of daily therapy for which they will be trained.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Mini - Assisting Hand Assessment
Time Frame: immediatly prior to treatment, immediately after treatment, 6 months after treatment, 12 months after treatment
|
functional assessment
|
immediatly prior to treatment, immediately after treatment, 6 months after treatment, 12 months after treatment
|
Change in the Bayley Infant Scales of Development
Time Frame: immediatly prior to treatment, immediately after treatment, 6 months after treatment, 12 months after treatment
|
functional assessment
|
immediatly prior to treatment, immediately after treatment, 6 months after treatment, 12 months after treatment
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01HD074574-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Centre Médico-Chirurgical de Réadaptation des Massues...RecruitingCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
St Mary's University CollegeUniversity of GloucestershireUnknownCerebral Palsy | Cerebral Palsy Ataxic | Cerebral Palsy, MixedUnited Kingdom
-
Hilde FeysHasselt University; ETH Zurich; Curtin UniversityRecruitingHemiplegic Cerebral Palsy | Cerebral Palsy, SpasticBelgium
-
University of California, San FranciscoNational Institutes of Health (NIH)RecruitingDystonic Cerebral Palsy | Dyskinetic Cerebral PalsyUnited States
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
October 6 UniversityCompletedSpastic Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyEgypt
-
Marmara UniversityUnknownCerebral Palsy, Spastic | Cerebral Palsy, Spastic, DiplegicTurkey
Clinical Trials on Neurorehabilitation therapy with cast
-
IRCCS National Neurological Institute "C. Mondino...CompletedParkinson Disease | Freezing of GaitItaly
-
China Medical University HospitalUnknownCerebrovascular AccidentTaiwan
-
Pamukkale UniversityRecruitingStroke | Spastic HemiplegiaTurkey
-
University College, LondonRecruiting
-
Université de SherbrookeBSN Medical IncCompletedWalking Cast Right Leg Immobilisation Effects | Aircast Right Leg Immobilisation EffectsCanada
-
AO Clinical Investigation and Publishing DocumentationTerminatedDiabetes Mellitus 1 or 2 | Midfoot Charcot NeuroarthropathyGermany
-
Riphah International UniversityCompleted
-
Université de SherbrookeFonds de la Recherche en Santé du Québec; BSN Medical IncCompletedAutomobile Driving With an Aircast Walker | Automobile Driving With a Walking CastCanada
-
St. Jude Children's Research HospitalCompletedBrain Tumor | HemiplegiaUnited States
-
Tel Aviv UniversityCompleted